Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Amendment to Performance Share Plan

14 Dec 2022 10:45

RNS Number : 6814J
DX (Group) PLC
14 December 2022
 

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Company Performance Share Plan

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, reports an amendment ("Amendment") to the Performance Condition of the Company's Performance Share Plan ("PSP"), which was established in December 2017 for directors and certain senior management of the Company ("Participants").

 

The Amendment introduces a further testing date of 21 December 2023, with the objective of retaining and fairly rewarding the 36 Participants, who are currently employed by the Group, in the PSP for a further year. The current third and final testing date for the PSP is on 21 December 2022 and the Amendment therefore extends the Performance Condition and adds a further measurement date in twelve months' time.

 

In light of the close proximity of the date of restoration of the Company's ordinary shares to trading on 19 October 2022 and the third testing date for the PSP under the plan on 21 December 2022, the Amendment creates additional time for the continued strong trading by the Group and its positive outlook to be recognised in a fair market price.

 

The Amendment also provides the further benefit of enabling DX to defer the implementation of a replacement Long Term Incentive Plan for a year and will help to retain and motivate the senior managers in the PSP.

 

A majority of shareholders of the Company's issued share capital, were consulted with respect to the Amendment.

 

Related party transaction

 

Under the AIM Rules for Companies, the Amendment to the PSP in relation to David Mulligan, Paul Ibbetson, Martin Illidge, Michael Sherry, and Kevin Galligan is classified as a Related Party Transaction. Accordingly, Mark Hammond, Mike Russell and Jon Kempster as Independent Directors consider, having consulted with finnCap, the Company's Nominated Adviser, that the terms of the Amendment are fair and reasonable insofar as its shareholders are concerned.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Jon Kempster, Senior Independent Non-executive Director

 Communications)

Mike Russell, Independent Non-executive Director

finnCap (Nominated Adviser & Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (ECM)

 

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALFELAFEA
Date   Source Headline
30th Oct 202310:10 amRNSForm 8.5 (EPT/RI)
30th Oct 20239:09 amRNSForm 8.5 (EPT/RI)
30th Oct 20237:00 amRNSEx-Tuffnells depot in Stafford reopened
27th Oct 202311:34 amRNSForm 8.5 (EPT/RI)
27th Oct 202310:43 amRNSForm 8.5 (EPT/RI)
26th Oct 202310:06 amRNSForm 8.5 (EPT/RI)
26th Oct 20238:35 amRNSForm 8.5 (EPT/RI)
25th Oct 20238:45 amRNSForm 8.5 (EPT/RI)
25th Oct 20238:41 amRNSForm 8.5 (EPT/RI)
24th Oct 20239:21 amRNSForm 8.5 (EPT/RI)
24th Oct 20238:31 amRNSForm 8.5 (EPT/RI)
23rd Oct 20238:57 amRNSForm 8.5 (EPT/RI)
20th Oct 20232:02 pmRNSForm 8.5 (EPT/RI)
20th Oct 20238:59 amRNSForm 8.5 (EPT/RI)
20th Oct 20238:54 amRNSForm 8.5 (EPT/RI)
19th Oct 20233:00 pmBUSForm 8.3 - DX. LN
19th Oct 20239:45 amRNSForm 8.5 (EPT/RI)
19th Oct 20239:30 amPRNForm 8.3 - DX (Group) plc
19th Oct 20238:36 amRNSForm 8.5 (EPT/RI)
18th Oct 20233:00 pmBUSForm 8.3 - DX. LN
18th Oct 20238:39 amRNSForm 8.5 (EPT/RI)
18th Oct 20238:34 amRNSForm 8.5 (EPT/RI)
17th Oct 20233:00 pmBUSForm 8.3 - DX. LN
17th Oct 20238:28 amRNSForm 8.5 (EPT/RI)
16th Oct 20239:01 amRNSForm 8.5 (EPT/RI)
16th Oct 20237:00 amRNSRe-opening of 10 former Tuffnells depots
13th Oct 20238:38 amRNSForm 8.5 (EPT/RI)
13th Oct 20238:28 amRNSPublication of Annual Report and Notice of AGM
13th Oct 20238:27 amRNSForm 8.5 (EPT/RI)
12th Oct 20238:57 amRNSForm 8.5 (EPT/RI)
12th Oct 20238:37 amRNSForm 8.5 (EPT/RI)
11th Oct 202310:31 amPRNForm 8.3 - DX (Group) Plc
11th Oct 20238:57 amRNSForm 8.5 (EPT/RI)
11th Oct 20238:37 amRNSForm 8.5 (EPT/RI)
10th Oct 20233:22 pmPRNForm 8.3 - DX (Group) Plc
10th Oct 20238:21 amRNSForm 8.5 (EPT/RI)
10th Oct 20238:15 amRNSForm 8.5 (EPT/RI)
9th Oct 20238:42 amRNSForm 8.5 (EPT/RI)
9th Oct 20238:32 amRNSForm 8.5 (EPT/RI)
9th Oct 20237:00 amRNSExtension of PUSU Deadline
6th Oct 202310:24 amRNSForm 8.5 (EPT/RI)
6th Oct 20239:02 amPRNForm 8.3 - DX (Group) PLC
6th Oct 20238:57 amRNSForm 8.5 (EPT/RI)
5th Oct 20239:28 amRNSForm 8.5 (EPT/RI)
5th Oct 20239:27 amPRNForm 8.3 - DX (Group) PLC
5th Oct 20238:41 amRNSForm 8.5 (EPT/RI)
4th Oct 20239:22 amRNSForm 8.5 (EPT/RI)
4th Oct 20238:42 amRNSForm 8.5 (EPT/RI)
3rd Oct 20232:43 pmRNSForm 8.5 (EPT/RI)
3rd Oct 20238:20 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.